Teenagers aged 16 and 17-years-old are to be offered the coronavirus vaccine in the coming weeks - and won't need parental consent to get the jab.
Ministers have accepted a recommendation by the Joint Committee on Vaccination and Immunisation (JCVI) on the vaccine rollout extension after the latest data was reviewed.
And the NHS is making preparations to start giving first doses to around 1.4 million children.
READ MORE:
Vaccination experts are yet to set out the timeline for when youngsters should get their second dose, and further recommendations will come at a later date.
Officials close to the programme said that under current UK guidance, if a child is able to understand the risks and benefits of any medical treatment, then they can legally give consent without their parents’ say-so.
The child or young person’s consent is considered the most appropriate consent, even if a parent disagrees.
It is understood officials are not ruling out vaccinations for otherwise healthy 12 to 15-year-olds but want to look at more information first.
Currently, children over the age of 12 are only eligible for a Covid vaccine if they have certain medical conditions that put them at risk from the virus or teenagers who live with people who are immunocompromised.
Youngsters will receive the Pfizer/BioNTech vaccine, which has been approved for use in the UK for people aged 12 and over.
Today's announcement comes after experts have been constantly reviewing the data on vaccines for children.
What do you make of the announcement? Have your say below
Information that had led them to reconsider the position on vaccinating children aged 16 and 17 included the recent surge of infections, more data on the safety of the vaccines and the excellent progress of the adult vaccination programme.
The JCVI said that a number of factors have been considered but the most important element was the risk/benefit of vaccination to the individual.
Before coming to the conclusion, the JCVI said it considered potential adverse reactions following vaccination, the frequency and severity of severe Covid in children and young people, the occurrence of long Covid in children and the mental health and educational impacts of Covid, among other factors.
Experts from the JCVI as well as those from the Medicines and Healthcare products Regulatory Agency (MHRA) constantly review safety reports of the vaccine, from both the UK and abroad.
They said they considered reports of heart inflammation among some younger adults who had the jab, but officials said that this was considered to be “extremely rare”, affecting around one in 100,000 people vaccinated. And the effects are “mild” with a short recovery period.
Children who have had the vaccine in clinical trials and real world data suggest that some get short-lived side effects after inoculation, including fever, sore arm, headache and tiredness.
The NHS will set out plans on the rollout of the programme shortly.
To get the latest email updates from the Manchester Evening News, click here.
